-

Bruker Introduces Enhanced 3D Holographic Stimulation for Optogenetics on its Ultima 2Pplus Multiphoton Microscope

New NeuraLight 3D Ultra Module Expands Neuroscience Research Capabilities

MADISON, Wis.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced the release of the NeuraLight 3D Ultra module to support advanced neuroscience and optogenetics research applications on Bruker’s Ultima multiphoton microscopes. NeuraLight 3D Ultra provides revolutionary 3D holographic photostimulation, specifically optimized for functional and large-scale studies of neural networks and brain computation. Building upon Bruker’s proprietary spatial light modulator (SLM) technology, the NeuraLight 3D Ultra module utilizes a new, larger liquid crystal chip that unlocks access to a larger field of view, improved targeting precision, and a market-leading speed of 600 hologram frames per second. Paired with the imaging capabilities of the Ultima 2Pplus microscope, it uniquely allows researchers to study mechanisms of behavior, perception, and disease at a larger scale and on a time scale that is reflective of the underlying biology.

“The system is performing very well in our laboratory, and we’re excited about the NeuraLight 3D Ultra’s speed, field of view, and resolution, which will enable us to perform all-optical interrogation experiments with greater fidelity and precision,” said Dr. Adam Packer, Wellcome Trust Sir Henry Dale Fellow at the University of Oxford. “The new format SLM and associated optical relays offer a better tradeoff between field of view and resolution that will be advantageous to addressing larger numbers of cells with improved accuracy. Additionally, the very fast update speed of the system will make it possible to activate sequences of cells at a high rate.”

“We are pleased to continue to develop innovative instrumentation in close collaboration with leaders in neuroscience research,” added Xiaomei Li, Ph.D., Vice President and General Manager for Bruker’s Fluorescence Microscopy Business. “With its largest in-class field of view in fast resonant mode, the Ultima 2Pplus microscope equipped with NeuraLight 3D Ultra is an optimized solution for all-optical interrogations of the brain.”

About NeuraLight 3D Ultra

The NeuraLight 3D Ultra is a module that strengthens and diversifies the functionality of Bruker’s Ultima multiphoton microscopes. These pioneering imaging systems have a proven track record of facilitating complex research in neuroscience and were first to enable simultaneous imaging and photostimulation of biological samples. NeuraLight 3D Ultra easily couples to one of the optical ports of the Ultima microscope to allow for independent imaging and simultaneous multicellular photostimulation. Comprehensive software enables user-friendly selection of targets in three dimensions with well-defined timing. The NeuraLight 3D Ultra module is available as an option for all new Ultima 2Pplus multiphoton microscopes and as an upgrade for selected models of microscopes produced since 2006. Ultima multiphoton systems equipped with NeuraLight 3D Ultra and paired with Bruker’s electrotunable lens option provide complete solutions for all-optical reading and writing of neuronal activity.

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com.

Contacts

Investor Contact:
Justin Ward
Senior Director, Investor Relations & Corporate Development
T: +1 (978) 663-3660 x1479
E: Investor.Relations@bruker.com

Media Contact:
Stephen Hopkins
Content Marketing Manager
T: +1 (520) 741-1044 x1022
E: steve.hopkins@bruker.com

Bruker Corporation

NASDAQ:BRKR

Release Versions
$Cashtags
Hashtags

Contacts

Investor Contact:
Justin Ward
Senior Director, Investor Relations & Corporate Development
T: +1 (978) 663-3660 x1479
E: Investor.Relations@bruker.com

Media Contact:
Stephen Hopkins
Content Marketing Manager
T: +1 (520) 741-1044 x1022
E: steve.hopkins@bruker.com

Social Media Profiles
More News From Bruker Corporation

Bruker Announces Quarterly Preferred Stock Dividend

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR, BRKRP) today announced that its Board of Directors (“Board”) has approved payment of a quarterly cash dividend in the amount of $3.9844 per share on the Company’s 6.375% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share (the “Mandatory Convertible Preferred Stock Dividend”). The Mandatory Convertible Preferred Stock Dividend will be paid on March 2, 2026 to stockholders of record as of February 15, 202...

Bruker Announces Date and Time of Fourth Quarter 2025 Earnings Release and Webcast

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2025 financial results before market opening on Thursday, February 12, 2026. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the “Q4 2025 Earnings Webcast” hyperlink in the “Events & Presentat...

Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRI

HANAU, Germany--(BUSINESS WIRE)--The Bruker Energy & Supercon Technologies (BEST) division, a segment of Bruker Corporation (Nasdaq: BRKR), today announced two multi-year supply agreements for Bruker’s latest superconductors, which are used by global radiology companies to build their next generations of magnetic resonance imaging (MRI) magnets. The combined order value of the two agreements is approximately $500 million in expected future BEST revenues, with different agreement duration pe...
Back to Newsroom